Related Experiment Videos
Epilogue: support devices for end stage heart failure
Mariell Jessup1, Susan C Brozena
1Heart Failure/Transplantation Program, University of Pennsylvania Medical Center, 6 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA. jessupm@uphs.upenn.edu
Cardiology Clinics
|June 7, 2003
Summary
Circulatory assist devices will shift from temporary rescue to primary treatment for advanced heart disease. This paradigm shift aims to improve patient survival and quality of life, potentially surpassing total heart replacement.
Area of Science:
- Cardiovascular medicine
- Biomedical engineering
- Medical device technology
Background:
- Current use of circulatory assist devices (CAD) is primarily as a bridge to transplant for patients in shock.
- Advanced heart disease significantly impacts patient survival and quality of life.
Purpose of the Study:
- To explore the future paradigm shift in the application of circulatory assist devices.
- To evaluate the potential of CAD as a primary treatment strategy for advanced heart disease.
Main Methods:
- Review of current trends and projected advancements in cardiovascular support technologies.
- Analysis of the potential impact of widespread CAD use on patient outcomes.
Main Results:
- The future of advanced heart disease management will likely involve more frequent use of CAD as a standalone therapy, rather than solely as a bridge to transplant.
- Strategic implementation of support devices may offer greater benefits than total heart replacement.
Conclusions:
- Circulatory assist devices are poised to become a cornerstone of advanced heart disease treatment, independent of transplantation.
- Widespread adoption of CAD promises enhanced survival and improved quality of life for patients with severe cardiac conditions.